ESPOSITO, Silvano
 Distribuzione geografica
Continente #
NA - Nord America 10.749
AS - Asia 4.494
EU - Europa 3.533
SA - Sud America 438
Continente sconosciuto - Info sul continente non disponibili 337
AF - Africa 109
OC - Oceania 10
Totale 19.670
Nazione #
US - Stati Uniti d'America 10.493
SG - Singapore 1.597
IT - Italia 1.310
HK - Hong Kong 974
CN - Cina 768
UA - Ucraina 654
VN - Vietnam 507
DE - Germania 366
BR - Brasile 324
RU - Federazione Russa 277
FI - Finlandia 228
FR - Francia 179
IE - Irlanda 179
TR - Turchia 168
KR - Corea 159
CA - Canada 128
SE - Svezia 90
GB - Regno Unito 88
IN - India 79
AR - Argentina 47
BD - Bangladesh 45
NL - Olanda 45
IQ - Iraq 35
ZA - Sudafrica 31
PL - Polonia 25
MX - Messico 24
JP - Giappone 22
ES - Italia 21
CO - Colombia 20
PK - Pakistan 19
ID - Indonesia 18
EC - Ecuador 17
GT - Guatemala 15
IL - Israele 15
PH - Filippine 15
SV - El Salvador 15
UZ - Uzbekistan 15
CR - Costa Rica 14
GP - Guadalupe 11
MA - Marocco 11
AT - Austria 10
EU - Europa 10
KE - Kenya 10
TT - Trinidad e Tobago 10
CZ - Repubblica Ceca 9
EG - Egitto 9
JO - Giordania 9
SC - Seychelles 9
TN - Tunisia 9
AU - Australia 8
CW - ???statistics.table.value.countryCode.CW??? 8
MY - Malesia 8
SA - Arabia Saudita 8
CL - Cile 7
DZ - Algeria 7
HN - Honduras 7
JM - Giamaica 7
LT - Lituania 7
PR - Porto Rico 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
NI - Nicaragua 6
VE - Venezuela 6
AZ - Azerbaigian 5
GR - Grecia 5
HR - Croazia 5
PE - Perù 5
RO - Romania 5
BO - Bolivia 4
BG - Bulgaria 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IR - Iran 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BE - Belgio 2
BS - Bahamas 2
CG - Congo 2
CU - Cuba 2
EE - Estonia 2
ET - Etiopia 2
GN - Guinea 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AL - Albania 1
Totale 19.330
Città #
Ann Arbor 1.981
Ashburn 1.018
Hong Kong 966
Wilmington 879
Jacksonville 800
Singapore 800
San Jose 729
Chandler 691
Princeton 575
Milan 455
Dallas 379
Woodbridge 368
Council Bluffs 324
Houston 306
Dong Ket 256
Dublin 179
Nanjing 166
Rome 147
Izmir 145
Andover 144
Munich 138
Lauterbourg 126
Pellezzano 117
Beijing 114
Boardman 108
The Dalles 100
São Paulo 96
Ho Chi Minh City 94
Los Angeles 63
Salerno 63
Hanoi 62
Mestre 62
Düsseldorf 61
New York 57
Fairfield 56
Santa Clara 55
Changsha 53
Helsinki 49
Shenyang 47
Moscow 45
Toronto 45
Hebei 43
Nanchang 43
Jiaxing 41
Brooklyn 32
Turku 30
Redwood City 26
Figino 25
Norwalk 25
Naples 24
Tianjin 24
Chicago 22
Tokyo 22
Warsaw 22
London 21
Turin 21
Johannesburg 19
Montreal 19
Ottawa 18
Cambridge 17
Phoenix 17
San Francisco 16
Stockholm 16
Chennai 15
Washington 15
Baghdad 14
Haiphong 14
San Diego 14
Frankfurt am Main 13
Orem 13
San José 13
San Salvador 13
Tashkent 13
Amsterdam 12
Da Nang 12
Bologna 11
Denver 11
Falls Church 11
Guangzhou 11
Manchester 11
Medellín 11
Mexico City 11
Napoli 11
Seattle 11
Jyväskylä 10
Lahore 10
Pune 10
Dearborn 9
Guatemala City 9
Las Vegas 9
Queens 9
Amman 8
Ankara 8
Charlotte 8
Columbus 8
Genoa 8
Jinan 8
Memphis 8
Meppel 8
Nairobi 8
Totale 13.860
Nome #
Bacterial Epidemiology and Antimicrobial Resistance in the Surgery Wards of a Large Teaching Hospital in Southern Italy 319
Epidemiology and microbiology of skin and soft tissue infections 303
Sphingomonas paucimobilis osteomyelitis in an immunocompetent patient. 280
Trattamento delle riacutizzazioni infettive di otiti croniche sostenute da stafilococco: studio aperto non comparativo con teicoplanina. 267
Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study 251
Irrigation and debridement 235
Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia 213
[Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry] 210
Surveillance of post-operative infections and management of antibiotic surgical prophylaxis in an Italian region 207
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones 197
Early discharge of infectious disease patients: an opportunity or extra cost for the Italian Healthcare System? 191
Amoxicillina/acido clavulanico nel trattamento delle otiti medie. 190
Adjuvant treatment of diabetic foot 189
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study 188
[Outpatient parenteral antibiotic therapy (OPAT) of diabetic foot infections with piperacillin/tazobactam] 187
Antibiotic prophylaxis in hernia repair and breast surgery: a prospective randomized study comparing piperacillin/tazobactam versus placebo 187
Diagnostic and therapeutic appropriateness in bone and joint infections: results of a national survey 186
Antibiotic resistance in long-term care facilities 185
Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist 184
A European survey of antibiotic management of methicillin-resistantStaphylococcus aureusinfection: current clinical opinion and practice 179
[Current guidelines for the treatment of intra-abdominal infections] 178
Attività batteriostatica e battericida di Levofloxacina e Ciprofloxacina verso uropatogeni determinata mediante MIC, MBC, Time-kill curves e analisi dell’indice di batteriocidia. 177
Bacterial meningitis complicating the course of liver cirrhosis 166
Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study 165
[Skin and soft tissue infections: classification and epidemiology] 165
Le infezioni del piede diabetico: aspetti microbiologici 164
Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens 162
[Catheter-associated urinary tract infections: epidemiology and prevention] 158
[Early and timely therapy: when to interrupt antibiotic therapy in nosocomial acquired pneumonia?] 156
[Skin and soft tissue infections: current therapeutic options] 154
Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: A comparison of two time periods 153
Infezioni da Staphylococcus aureus meticillino-resistente: Ruolo dell’associazione daptomicina/β-lattamici 152
Listeria monocytogenes meningitis in the elderly: Epidemiological, clinical and therapeutic findings 148
Antibiotic prophylaxis in catheter-associated urinary infections. 146
Il trattamento delle infezioni batteriche in comunità: il modello italiano come modello internazionale? 145
Valutazione clinica della Sultamicillina in confronto alla amoxicillina nel trattamento delle infezioni urinarie, respiratorie ed ORL 145
Factors related to outcome of early and delayed prosthetic joint infections. 144
In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer. 140
Ciprofloxacin in the treatment of severe bacterial infections. 140
Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey 140
Deep tissue biopsy vs. superficial swab culture, including microbial loading determination, in the microbiological assessment of Skin and Soft Tissue Infections (SSTIs) 139
Transient bacteraemia due to Chryseobacterium indologenes in an immunocompetent patient: a case report and literature review 138
Aggiornamenti in tema di infezioni del piede diabetico 136
Antibiotic prophylaxis in surgery: an observational prospective study conducted in a large teaching hospital in Naples. 135
Analysis of current guidelines for the treatment of skin and soft tissue infections 135
Antibiotic dose adjustment in patients with advanced liver disease. 135
In vitro activity of tigecycline: MICs, MBCs, time-kill curves and post-antibiotic effect 135
Attività antibatterica del cefuroxime in colture miste in un modello in vitro di farmacodinamica. 134
[Update on diabetic foot infections.] 134
Multicentre survey of post-surgical infections in Campania (Italy) 134
Infezioni batteriche in una popolazione di pazienti cirrotici: prevalenza e fattori di rischio associati. 133
Sensibilità in vitro dei batteri Gram positivi di maggiore rilevanza clinica, Studio multicentrico. 132
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens] 131
Prosthetic joint infections: microbiology, diagnosis, management and prevention 130
Lymph node fine needle cytology in infectious diseases: A clinical perspective 130
La complessità della terapia antibiotica nel piede diabetico infetto 130
Efficacia terapeutica di ciprofloxacina orale nei confronti di gentamicina parenterale nelle infezioni da pseudomonas dell'orecchio medio. 129
Adverse effects of intravenous antibiotic therapy. 128
Italian Guidelines for the Diagnosis and Infectious Disease Management of Osteomyelitis and Prosthetic Joint Infections in Adults 126
Imipenem/cilastatina versus ceftazidime nel trattamento delle infezioni batteriche dell'orecchio medio 125
Le infezioni del piede diabetico: aspetti microbiologici. Diabetic foot infections: microbiological aspects 125
Lesioni infette del piede diabetico. Infected lesions of diabetic foot 124
Antimicrobial therapy duration: a major matter in the management of severe infections. 124
New insights into classification, epidemiology and microbiology of SSTIs, including diabetic foot infections 124
Esperienze cliniche con Ceftazidime in medicina. 123
Trattamento delle infezioni batteriche nei pazienti anziani con Imipenem/cilastatina: studio aperto non comparativo 122
Sepsis and septic shock: New definitions, new diagnostic and therapeutic approaches 121
Considerations on antibiotic therapy duration in community- and hospital-acquired bacterial infections 120
International OPAT Registry. Outpatint parenteral antibiotic therapy (OPAT) in different countries: a comparison. 120
Ofloxacina per via topica versus Ceftazidime per via intramuscolare nel trattamento delle infezioni dell'orecchio medio. 120
Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus 120
Percutaneous liver biopsy and transient bacteremia 119
New insights in biological targets and therapeutic management of infectious diseases. 119
Epidemiology and antibiotic resistance in a large Italian teaching hospital 119
Management of severe bacterial infections and role of the infectious disease specialist: results of an interview-based survey 119
Changes in intestinal microflora induced by ciprofloxacin and treatment of portal systemic encephalopaty 118
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 117
Newinsights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis,treatment and resistance. 116
Antibiotici ed Immunità 116
Visceral leishamiosis in immunocompromised host: an update and literature review. 116
Ruolo patogenetico dell’Helicobacter pylori nelle malattie gastroduodenali. 115
Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital 115
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. 114
Uso locale della gentamicina per il trattamento delle otiti medie croniche riacutizzate. 113
Intestinal helminths in immigrants in Naples (Italy): a comparison between two different diagnostic techniques 113
Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: A 2014 follow-up survey 113
null 111
Comment on: outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. 110
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 110
Outpatient Care: an international consensus statement on non-inpatient parenteral therapy. 107
Hot topics in the diagnosis and management of skin and soft-tissue infections. 107
Emerging antibiotic resistance: carbapenemase-producing enterobacteria. New bad bugs, still no new drugs 107
Il cipropfloxacin nel trattamento delle infezioni gastrointestinali. 106
Raccolta di esperienze cliniche nell’uso di Ceftriaxone in profilassi chirurgica: introduzione. 106
Cefaclor nella faringotonsillite streptococcica in età pediatrica: ruolo della durata della terapia. 105
Modification of patients' endogenous bacterial flora during hospitalization in a large teaching hospital in Naples. 104
Attualità in tema di antibiotico-profilassi in chirurgia. 103
Diabetic foot: definitions. 103
Changes in intestinal microflora following levofloxacin administration in laboratory animals 103
Ciprofloxacin in the treatment of UTI and RTI in patients affected by chonic liver diseases. 102
Totale 14.664
Categoria #
all - tutte 62.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022972 0 0 0 1 28 20 6 35 150 143 138 451
2022/20231.623 170 74 17 189 269 322 7 203 251 5 89 27
2023/2024552 65 94 38 23 41 61 9 42 6 52 21 100
2024/20251.537 78 34 25 75 53 204 276 211 234 32 194 121
2025/20265.929 274 646 696 200 620 335 1.193 234 269 665 77 720
2026/20271.905 186 142 448 1.129 0 0 0 0 0 0 0 0
Totale 19.670